342 related articles for article (PubMed ID: 34196731)
1. Targeting cancer via ribosome biogenesis: the cachexia perspective.
Figueiredo VC; McCarthy JJ
Cell Mol Life Sci; 2021 Aug; 78(15):5775-5787. PubMed ID: 34196731
[TBL] [Abstract][Full Text] [Related]
2. Reduced rDNA transcription diminishes skeletal muscle ribosomal capacity and protein synthesis in cancer cachexia.
Kim HG; Huot JR; Pin F; Guo B; Bonetto A; Nader GA
FASEB J; 2021 Feb; 35(2):e21335. PubMed ID: 33527503
[TBL] [Abstract][Full Text] [Related]
3. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.
Scala F; Brighenti E; Govoni M; Imbrogno E; Fornari F; Treré D; Montanaro L; Derenzini M
Oncogene; 2016 Feb; 35(8):977-89. PubMed ID: 25961931
[TBL] [Abstract][Full Text] [Related]
4. Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics.
Catez F; Dalla Venezia N; Marcel V; Zorbas C; Lafontaine DLJ; Diaz JJ
Biochem Pharmacol; 2019 Jan; 159():74-81. PubMed ID: 30468711
[TBL] [Abstract][Full Text] [Related]
5. Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why.
Derenzini E; Rossi A; Treré D
J Hematol Oncol; 2018 May; 11(1):75. PubMed ID: 29855342
[TBL] [Abstract][Full Text] [Related]
6. Platinum-induced muscle wasting in cancer chemotherapy: Mechanisms and potential targets for therapeutic intervention.
Moreira-Pais A; Ferreira R; Gil da Costa R
Life Sci; 2018 Sep; 208():1-9. PubMed ID: 30146014
[TBL] [Abstract][Full Text] [Related]
7. PGC1α overexpression preserves muscle mass and function in cisplatin-induced cachexia.
Huot JR; Pin F; Chatterjee R; Bonetto A
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2480-2491. PubMed ID: 35903870
[TBL] [Abstract][Full Text] [Related]
8. Ribosome biogenesis in skeletal muscle: coordination of transcription and translation.
von Walden F
J Appl Physiol (1985); 2019 Aug; 127(2):591-598. PubMed ID: 31219775
[TBL] [Abstract][Full Text] [Related]
9. Ribosome biogenesis: emerging evidence for a central role in the regulation of skeletal muscle mass.
Chaillou T; Kirby TJ; McCarthy JJ
J Cell Physiol; 2014 Nov; 229(11):1584-94. PubMed ID: 24604615
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
[TBL] [Abstract][Full Text] [Related]
11. Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
Brighenti E; Treré D; Derenzini M
Oncotarget; 2015 Nov; 6(36):38617-27. PubMed ID: 26415219
[TBL] [Abstract][Full Text] [Related]
12. Cancer cachexia: molecular mechanism and pharmacological management.
Li Y; Jin H; Chen Y; Huang T; Mi Y; Zou Z
Biochem J; 2021 May; 478(9):1663-1688. PubMed ID: 33970218
[TBL] [Abstract][Full Text] [Related]
13. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
[TBL] [Abstract][Full Text] [Related]
14. The effects of age and resistance loading on skeletal muscle ribosome biogenesis.
Stec MJ; Mayhew DL; Bamman MM
J Appl Physiol (1985); 2015 Oct; 119(8):851-7. PubMed ID: 26294750
[TBL] [Abstract][Full Text] [Related]
15. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
16. Ribosome biogenesis may augment resistance training-induced myofiber hypertrophy and is required for myotube growth in vitro.
Stec MJ; Kelly NA; Many GM; Windham ST; Tuggle SC; Bamman MM
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E652-E661. PubMed ID: 26860985
[TBL] [Abstract][Full Text] [Related]
17. F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.
Sukari A; Muqbil I; Mohammad RM; Philip PA; Azmi AS
Semin Cancer Biol; 2016 Feb; 36():95-104. PubMed ID: 26804424
[TBL] [Abstract][Full Text] [Related]
18. Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.
VanderVeen BN; Fix DK; Carson JA
Oxid Med Cell Longev; 2017; 2017():3292087. PubMed ID: 28785374
[TBL] [Abstract][Full Text] [Related]
19. Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice.
Chen MC; Hsu WL; Hwang PA; Chen YL; Chou TC
Oncotarget; 2016 Aug; 7(32):51608-51618. PubMed ID: 27323407
[TBL] [Abstract][Full Text] [Related]
20. Blunted hypertrophic response in aged skeletal muscle is associated with decreased ribosome biogenesis.
Kirby TJ; Lee JD; England JH; Chaillou T; Esser KA; McCarthy JJ
J Appl Physiol (1985); 2015 Aug; 119(4):321-7. PubMed ID: 26048973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
